Similarly, the inhibition of mTOR (oral gavage for 21 days-3 mg/kg twice daily 3 x/week in EWS and RMS, or 2.5 mg/kg, daily) in OS resulted in tumor volume reduction, without observable side effects [795,796]. The gene discussed is MTOR; the disease is neoplasm.